Article Navigation
Article Contents
-
ABSTRACT
-
Introduction
-
Case presentation
-
Discussion
-
Acknowledgements
-
Conflict of interest
-
Funding
-
Patient consent
-
Ethical approval
-
References
- < Previous
- Next >
Journal Article Selected Paper
, Kazuma Ino Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Yoshiyuki Arinuma Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Masashi Akiya Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research , Tokyo, Japan Search for other works by this author on: Oxford Academic Sabine Kajita Department of Pathology, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Sosei Okina Department of Hematology, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Junichi Sakamoto Department of Gastrointestinal Surgery, Ageo Central General Hospital , Saitama, Japan Search for other works by this author on: Oxford Academic Tomoki Tanaka Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Yu Matsueda Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Tatsuhiko Wada Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Sumiaki Tanaka Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic
, Kenji Oku Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan Search for other works by this author on: Oxford Academic Kunihiro Yamaoka Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine , Kanagawa, Japan *Correspondence: Kunihiro Yamaoka; yamaoka@med.kitasato-u.ac.jp; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan. Search for other works by this author on: Oxford Academic
Modern Rheumatology Case Reports, Volume 8, Issue 2, July 2024, Pages 323–328, https://doi.org/10.1093/mrcr/rxae012
Published:
28 March 2024
Article history
Received:
21 November 2023
Revision received:
18 February 2024
Accepted:
26 February 2024
Published:
28 March 2024
Corrected and typeset:
01 April 2024
- Split View
- Views
- Article contents
- Figures & tables
- Video
- Audio
- Supplementary Data
-
Cite
Cite
Kazuma Ino, Yoshiyuki Arinuma, Masashi Akiya, Sabine Kajita, Sosei Okina, Junichi Sakamoto, Tomoki Tanaka, Yu Matsueda, Tatsuhiko Wada, Sumiaki Tanaka, Kenji Oku, Kunihiro Yamaoka, IgG4-related disease complicated with diffuse and chronic gastrointestinal inflammation leading to small intestinal perforation, Modern Rheumatology Case Reports, Volume 8, Issue 2, July 2024, Pages 323–328, https://doi.org/10.1093/mrcr/rxae012
Close
Search
Close
Search
Advanced Search
Search Menu
ABSTRACT
Immunoglobulin (Ig) G4–related disease (IgG4-RD) is a systemic inflammatory disease characterised by elevated serum IgG4, IgG4+ cell infiltration, storiform fibrosis, and obliterative phlebitis. While IgG4-RD can affect various organs, gastrointestinal tract involvement is less common. Here, we report a 70-year-old female with IgG4-RD complicated with diffuse and chronic gastrointestinal inflammation, which led to small intestinal perforation. She had been suffering from anorexia, abdominal pain, vomiting, and diarrhoea and hospitalised due to recurrent ileus. Consequently, she was referred due to small intestinal perforation required for surgical intervention. Pathology revealed acute and chronic inflammation with massive IgG4+ plasmacyte infiltration into mucosa of the small intestine and ischaemic change secondarily caused by chronic inflammation. Random biopsies from the mucosa of stomach, duodenum, ileum, and colon also revealed diffuse and massive IgG4+ plasmacyte infiltration in stomach, duodenum, small intestine, and colon. She was diagnosed with IgG4-RD based on the pathological findings and elevated serum IgG4 levels. Glucocorticoid rapidly ameliorated the symptoms. IgG4-RD may cause gastrointestinal manifestations, and histopathological assessment should be considered, even in the absence of specific characteristics of IgG4-RD.
Immunoglobulin (Ig) G4–related disease (IgG4-RD), ileus, diffuse and chronic gastrointestinal inflammation, small intestinal perforation, glucocorticoid
Introduction
Immunoglobulin (Ig) G4–related disease (IgG4-RD) is a systemic inflammatory disease involving multiple organs characterised by serum IgG4 elevation and histopathological IgG4+ cell infiltration, storiform fibrosis, and obliterative phlebitis. It is well known to be mainly involved with lachrymal and salivary glands, pituitary, lymph nodes, kidney, pancreas, bile duct, retroperitoneum, and artery, although gastrointestinal tract is less common [1, 2]. Previously, various types of gastrointestinal lesions have been reported, such as wall thickening, ulcer, tumour, polyp, and appendicitis [3–7]. However, there have been few case reports of small intestinal lesions [8–16], and furthermore, there has been no case report of diffuse gastrointestinal inflammation leading to perforation. We herein report the first case of IgG4-RD complicated with diffuse and chronic gastrointestinal inflammation leading to small intestinal perforation.
Case presentation
A 70-year-old female, who had past histories of cholecystectomy, appendectomy, and tonsillectomy and had no histories of taking nonsteroidal anti-inflammatory drugs, Helicobacter Pylori infection, inflammatory bowel diseases, and allergic diseases, was presented with anorexia, abdominal pain, vomiting, and diarrhoea. She was admitted due to ileus, relieved by conservative therapy. However, her symptoms were recurrent, requiring several hospitalisations. Two months later, she subsequently developed gastrointestinal perforation and was transferred to our emergency department.
On arrival, the body temperature was 37.6˚C with abdominal rebound tenderness. The laboratory test revealed leucocytosis, hypoproteinaemia, hypoalbuminaemia, an elevated C-reactive protein (CRP) and a soluble interleukin-2 receptor (sIL-2R), and coagulopathy (Table1). Contrast-enhanced computed tomography (CT) scan showed oedematous and dilated duodenum, small intestine, and colon, as well as free air in the abdominal cavity and multiple mesenteric and para-aortic lymphadenopathies [Figure1(a–c)]. Urgent surgery was performed for suspected gastrointestinal perforation due to malignant lymphoma. The small intestine was found to be partially black, and entirely dilated, erythematous and oedematous with strong interloop adhesions, indicating ischaemic changes and chronic inflammation, respectively [Figure1(d)]. As a result, the purulent ascites was drained and three perforated sites in the small intestine and regional lymph nodes were resected. The postoperative course was uneventful, and the patient was discharged 13 days after surgery, although she continued to experience abdominal pain, vomiting, and diarrhoea.
Figure1.
Contrast-enhanced CT and resected small intestine. Contrast-enhanced CT showed free air in the abdominal cavity (asterisks), oedematous and dilated duodenum (triangle) (a), small intestine (triangles) (b), colon (triangles) (c), and multiple mesenteric and para-aortic lymphadenopathies (arrows) (d). Resected small intestine appeared partially black, indicative of ischaemic change (triangle), and entirely dilated, reddened, and oedematous, forming strong interloop adhesions, indicative of chronic inflammation (arrow).
Open in new tabDownload slide
Table1.
Open in new tab
Laboratory test on admission.
Complete blood count | Biochemistry | ||
---|---|---|---|
White blood cell | 10,100/μl | Total protein | 5.0 g/dl |
Neutrophil | 79.4% | Albumin | 1.8 g/dl |
Eosinophil | 0.2% | Urea nitrogen | 15.0 mg/dl |
Lymphocyte | 19.2% | Creatinine | 0.92 mg/dl |
Monocyte | 0.9% | Total bilirubin | 0.7 mg/dl |
Basophil | 0.3% | Aspartate aminotransferase | 14 U/l |
Red blood cell | 3.58 × 106/μl | Alanine aminotransferase | 5 U/l |
Hemoglobin | 10.2 g/dl | Alkaline phosphatase | 145 U/l |
Plt | 27.4 × 104/μl | Amylase | 122 U/l |
Lactate dehydrogenase | 165 U/l | ||
Coagulation | Creatine kinase | 36 U/l | |
Prothrombin time-international normalized ratio | 1.13 | Na | 130 mEq/l |
Activated partial thromboplastin time | 44.1 s | K | 3.9 mEq/l |
Fibrinogen | 552 mg/dl | Cl | 99 mEq/l |
Fibrin degradation product | 17.4 μg/ml | CRP | 24.9 mg/dl |
d-Dimer | 7.3 μg/ml | sIL-2R | 1920 U/ml |
Complete blood count | Biochemistry | ||
---|---|---|---|
White blood cell | 10,100/μl | Total protein | 5.0 g/dl |
Neutrophil | 79.4% | Albumin | 1.8 g/dl |
Eosinophil | 0.2% | Urea nitrogen | 15.0 mg/dl |
Lymphocyte | 19.2% | Creatinine | 0.92 mg/dl |
Monocyte | 0.9% | Total bilirubin | 0.7 mg/dl |
Basophil | 0.3% | Aspartate aminotransferase | 14 U/l |
Red blood cell | 3.58 × 106/μl | Alanine aminotransferase | 5 U/l |
Hemoglobin | 10.2 g/dl | Alkaline phosphatase | 145 U/l |
Plt | 27.4 × 104/μl | Amylase | 122 U/l |
Lactate dehydrogenase | 165 U/l | ||
Coagulation | Creatine kinase | 36 U/l | |
Prothrombin time-international normalized ratio | 1.13 | Na | 130 mEq/l |
Activated partial thromboplastin time | 44.1 s | K | 3.9 mEq/l |
Fibrinogen | 552 mg/dl | Cl | 99 mEq/l |
Fibrin degradation product | 17.4 μg/ml | CRP | 24.9 mg/dl |
d-Dimer | 7.3 μg/ml | sIL-2R | 1920 U/ml |
Table1.
Open in new tab
Laboratory test on admission.
Complete blood count | Biochemistry | ||
---|---|---|---|
White blood cell | 10,100/μl | Total protein | 5.0 g/dl |
Neutrophil | 79.4% | Albumin | 1.8 g/dl |
Eosinophil | 0.2% | Urea nitrogen | 15.0 mg/dl |
Lymphocyte | 19.2% | Creatinine | 0.92 mg/dl |
Monocyte | 0.9% | Total bilirubin | 0.7 mg/dl |
Basophil | 0.3% | Aspartate aminotransferase | 14 U/l |
Red blood cell | 3.58 × 106/μl | Alanine aminotransferase | 5 U/l |
Hemoglobin | 10.2 g/dl | Alkaline phosphatase | 145 U/l |
Plt | 27.4 × 104/μl | Amylase | 122 U/l |
Lactate dehydrogenase | 165 U/l | ||
Coagulation | Creatine kinase | 36 U/l | |
Prothrombin time-international normalized ratio | 1.13 | Na | 130 mEq/l |
Activated partial thromboplastin time | 44.1 s | K | 3.9 mEq/l |
Fibrinogen | 552 mg/dl | Cl | 99 mEq/l |
Fibrin degradation product | 17.4 μg/ml | CRP | 24.9 mg/dl |
d-Dimer | 7.3 μg/ml | sIL-2R | 1920 U/ml |
Complete blood count | Biochemistry | ||
---|---|---|---|
White blood cell | 10,100/μl | Total protein | 5.0 g/dl |
Neutrophil | 79.4% | Albumin | 1.8 g/dl |
Eosinophil | 0.2% | Urea nitrogen | 15.0 mg/dl |
Lymphocyte | 19.2% | Creatinine | 0.92 mg/dl |
Monocyte | 0.9% | Total bilirubin | 0.7 mg/dl |
Basophil | 0.3% | Aspartate aminotransferase | 14 U/l |
Red blood cell | 3.58 × 106/μl | Alanine aminotransferase | 5 U/l |
Hemoglobin | 10.2 g/dl | Alkaline phosphatase | 145 U/l |
Plt | 27.4 × 104/μl | Amylase | 122 U/l |
Lactate dehydrogenase | 165 U/l | ||
Coagulation | Creatine kinase | 36 U/l | |
Prothrombin time-international normalized ratio | 1.13 | Na | 130 mEq/l |
Activated partial thromboplastin time | 44.1 s | K | 3.9 mEq/l |
Fibrinogen | 552 mg/dl | Cl | 99 mEq/l |
Fibrin degradation product | 17.4 μg/ml | CRP | 24.9 mg/dl |
d-Dimer | 7.3 μg/ml | sIL-2R | 1920 U/ml |
Pathological examination of resected small intestine revealed massive transmural inflammation [Figure2(a)]. In addition, most of the mesenteric small arteries were occluded both in the area of ischemic changes and at the perforated sites [Figure2(b)]. Elastica van Gieson staining revealed intimal thickening of the arteries without necrotizing vasculitis and tearing of the internal elastic lamina [Figure2(c)], which was surrounded by the plasmacytes. There was no evidence of malignancy, monoclonal cell proliferation, and light chain restriction. Thus, occlusion of mesenteric small arteries was considered to be the cause of small intestine perforation. The regional lymph node showed follicles with plasmacytic proliferation, increased hypervascularisation slightly penetrating the atrophic germinal centre without hyalinisation, and enlarged sinuses [Figure2(d)]. These features included the absence of mature plasma cell sheet-like proliferation, marked hemosiderin deposition, or marked neutrophilic infiltration. The observed features were not conclusive enough to diagnose Castleman’s disease. Interestingly, immunohistochemistry showed massive IgG4+ and cluster of differentiation (CD) 138+ plasmacyte infiltration in the mucosa of the perforated site [Figure2(e)] and regional lymph node with IgG4+ plasmacytes >10 per high power field (HPF) and IgG4/IgG ratios >95% without storiform fibrosis and obliterative phlebitis [Figure2(f,g)]. Plasmacytes surrounding small arteries with occlusion and intima thickening were also positive for IgG4+ [Figure2(h)]. In addition, serum IgG and IgG4 levels were found to be elevated at 2278 mg/dl and 969 mg/dl, respectively. Furthermore, serum C3 levels were decreased to 52 mg/dl. Thus, the patient was suspected of IgG4-RD and referred to our department.
Figure2.
The pathological findings of resected specimens. Resected small intestine showed massive transmural inflammation with lymphoplasmacytic infiltration [(a) hematoxylin and eosin (HE) staining ×40]. Most mesenteric small arteries were occluded in the partially turned black and perforated sites of small intestine [(b) HE staining ×40], with intimal thickening of the arteries [(c) Elastica van Gieson staining ×40]. Regional lymph node showed follicles with plasmacyte proliferation, increased hypervascularisation slightly penetrating the atrophic germinal centre without hyalinisation, and enlarged sinuses [(d) HE staining ×40]. CD138+ and IgG4+ plasmacytes infiltrated into mucosa of the perforated site [(e) IgG4 staining ×40], and regional lymph node was with a IgG4/IgG ratio of >95% without storiform fibrosis and obliterative phlebitis [(f) IgG staining ×40 and (g) IgG4 staining ×40]. IgG4+ plasmacytes were detected surrounding the small arteries with occlusion and intima thickening [(h) IgG4 staining ×400, red arrow].
Open in new tabDownload slide
Random biopsies of the gastric, duodenum, ileal, and colonic mucosa were performed to evaluate the extensive lesions. Pathology revealed diffuse and massive infiltration of IgG4+ and CD138+ plasmacytes (all specimens demonstrated IgG4+ plasmacytes >10 per HPF, and the IgG4/IgG ratio was >50%, >95%, >95%, and >95%, respectively), yet endoscopically, the mucosa was intact [Figure3(a–h)]. Storiform fibrosis and obliterative phlebitis were not observed. Subsequent clinical evaluation revealed no other causes that could explain the patient’s condition. In particular, the patient denied a history of fever, skin rash, arthralgia, or other constitutional symptoms. Autoantibody examination, including antinuclear antibody and antineutrophil cytoplasmic antibody (ANCA), was negative (Table2), as were serologies for hepatitis B virus, hepatitis C virus, and H. pylori. Whole-body examination revealed no other organ involvement. Despite not fully satisfying the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-RD [17], according to the 2020 revised comprehensive diagnostic criteria for IgG4-RD [18], the diagnosis of IgG4-RD was made based on an elevated serum IgG4 and diffuse infiltration of IgG4+ plasmacytes into gastrointestinal tract after excluding other causes. 18F-fluorodeoxyglucose positron emission tomography CT was not performed at this time. Treatment with 30 mg/day prednisolone (PSL) rapidly ameliorated symptoms and was gradually reduced to 10 mg maintaining remission (Figure4). The CT abnormalities disappeared 4 months after initiation of treatment (Figure5), and she has been in remission with 10 mg/day PSL.
Figure3.
Immunohistochemical staining. Immunohistochemical staining revealed diffuse and massive infiltration of IgG4+ plasmacytes in the stomach [(a) IgG staining ×40 and (b) IgG4 staining ×40], duodenum [(c) IgG staining ×40 and (d) IgG4 staining ×40], ileum [(e) IgG staining ×40 and (f) IgG4 staining ×40], and transverse colon [(g) IgG staining ×40 and (h) IgG4 staining ×40]. The IgG4/IgG ratio was >50%, >95%, >95%, and >95%, respectively.
Open in new tabDownload slide
Figure4.
The course of treatment. Treatment with 30 mg/day PSL rapidly ameliorated the symptoms and gradually reduced to 10 mg with remission.
Open in new tabDownload slide
Figure5.
Contrast-enhanced CT 4 months after treatment was initiated. Contrast-enhanced CT 4 months after treatment was initiated demonstrated that duodenum, small intestine, and colon returned to normal, and multiple mesenteric lymphadenopathies disappeared.
Open in new tabDownload slide
Table2.
Open in new tab
Additional laboratory test.
IgG | 2278 mg/dl |
IgA | 100 mg/dl |
IgM | 79 mg/dl |
IgG4 (latex turbidimetric immunoassay) | 969 mg/dl |
C3 | 52 mg/dl |
C4 | 16 mg/dl |
CH50 | 31 U/l |
IL-6 | 9.3 pg/ml |
Antinuclear antibody | <40 |
Anti-DNA antibody | <2.0 IU/ml |
Anti-RNP antibody | <2.0 U/ml |
Anti-Scl-70 antibody | <1.0 U/ml |
Anti-Sm antibody | <1.0 U/ml |
Anti-SS-A antibody | <1.0 U/ml |
Anti-SS-B antibody | <1.0 U/ml |
MPO-ANCA | <1.0 U/ml |
PR3-ANCA | <1.0 U/ml |
Antimitochondrial M2 antibody | <1.5 |
ACE | 8.3 U/l |
Lysozyme | 6.2 µg/ml |
IgG | 2278 mg/dl |
IgA | 100 mg/dl |
IgM | 79 mg/dl |
IgG4 (latex turbidimetric immunoassay) | 969 mg/dl |
C3 | 52 mg/dl |
C4 | 16 mg/dl |
CH50 | 31 U/l |
IL-6 | 9.3 pg/ml |
Antinuclear antibody | <40 |
Anti-DNA antibody | <2.0 IU/ml |
Anti-RNP antibody | <2.0 U/ml |
Anti-Scl-70 antibody | <1.0 U/ml |
Anti-Sm antibody | <1.0 U/ml |
Anti-SS-A antibody | <1.0 U/ml |
Anti-SS-B antibody | <1.0 U/ml |
MPO-ANCA | <1.0 U/ml |
PR3-ANCA | <1.0 U/ml |
Antimitochondrial M2 antibody | <1.5 |
ACE | 8.3 U/l |
Lysozyme | 6.2 µg/ml |
Table2.
Open in new tab
Additional laboratory test.
IgG | 2278 mg/dl |
IgA | 100 mg/dl |
IgM | 79 mg/dl |
IgG4 (latex turbidimetric immunoassay) | 969 mg/dl |
C3 | 52 mg/dl |
C4 | 16 mg/dl |
CH50 | 31 U/l |
IL-6 | 9.3 pg/ml |
Antinuclear antibody | <40 |
Anti-DNA antibody | <2.0 IU/ml |
Anti-RNP antibody | <2.0 U/ml |
Anti-Scl-70 antibody | <1.0 U/ml |
Anti-Sm antibody | <1.0 U/ml |
Anti-SS-A antibody | <1.0 U/ml |
Anti-SS-B antibody | <1.0 U/ml |
MPO-ANCA | <1.0 U/ml |
PR3-ANCA | <1.0 U/ml |
Antimitochondrial M2 antibody | <1.5 |
ACE | 8.3 U/l |
Lysozyme | 6.2 µg/ml |
IgG | 2278 mg/dl |
IgA | 100 mg/dl |
IgM | 79 mg/dl |
IgG4 (latex turbidimetric immunoassay) | 969 mg/dl |
C3 | 52 mg/dl |
C4 | 16 mg/dl |
CH50 | 31 U/l |
IL-6 | 9.3 pg/ml |
Antinuclear antibody | <40 |
Anti-DNA antibody | <2.0 IU/ml |
Anti-RNP antibody | <2.0 U/ml |
Anti-Scl-70 antibody | <1.0 U/ml |
Anti-Sm antibody | <1.0 U/ml |
Anti-SS-A antibody | <1.0 U/ml |
Anti-SS-B antibody | <1.0 U/ml |
MPO-ANCA | <1.0 U/ml |
PR3-ANCA | <1.0 U/ml |
Antimitochondrial M2 antibody | <1.5 |
ACE | 8.3 U/l |
Lysozyme | 6.2 µg/ml |
Discussion
Nine cases of IgG4-RD with small intestinal lesions have been reported [8–16] (Table3). All these cases were diagnosed based on pathological findings: six cases through surgical resection [8, 9, 12, 14–16], one case via double balloon small intestinal endoscopy [10], and two cases through endoscopic biopsy [11, 13].
Table3.
Open in new tab
The summary of cases of IgG4-RD with small intestinal lesion.
Age (years) /Sex [Ref. No.] | Symptoms | Lesion | Histopathology and immunohistochemical staining | Serum IgG4 (mg/dl) | Other organ involvement | Treatment | Outcome |
---|---|---|---|---|---|---|---|
46/female [8] | Abdominal pain Vomiting | Jejunal ulcer | IgG4+ lymphoplasmacytic infiltration IgG4+ >60/HPF IgG4/IgG ratio >40% Necrotising mesenteric arteritis | 1540 | None | Jejunum resection →PSL, MMF | 5-week recurrence free |
43/male [9] | Abdominal pain | Ileum stricture and dilatation | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Fibrosis Obliterative phlebitis | N/A | None | Ileum resection | N/A |
55/male [10] | Abdominal pain General fatigue | Multiple erosions and ulcers of jejunum, stomach, and colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 70% | 2480 | AIP Cervical lymph node Nephritis (not biopsied) | PSL 40 mg/day | 3-month recurrence free |
70/male [11] | Abdominal pain Cognitive decline Gait disturbance | Multiple erosions and ulcers of ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 83.2% (dura) IgG4+ >90/HPF (dura) IgG4/IgG ratio >50% (ileum) IgG4+ >20/HPF (ileum) | 393 | Pachymeningitis | Steroid pulse therapy →PSL 10 mg/day | 2-month recurrence free |
54/female [12] | Colicky abdominal pain | Submucosal mass of terminal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis Obliterative phlebitis | N/A | None | Right hemicolectomy | 1-Year recurrence free |
72/female [13] | Abdominal pain Diarrheal | Chronic duodenitis and ileitis | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio >40% IgG4 >10/HPF | 2670 | Submandibular Pancreas | PSL 30 mg/day | 2-Year recurrence free |
69/male [14] | Repeated gastrointestinal tract obstruction | Two oedematous and stenosed lesions in ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 87% | 52.0 | None | Ileum resection | 1-Year recurrence free |
74/female [15] | Abdominal pain Slight fever | Oedematous and thick lesion from terminal ileum to lower ascending colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 50% IgG4 150/HPF | 102 | None | Right hemicolectomy | 10-Month recurrence free |
81/female [16] | Abdominal pain Dyspepsia Hematochezia | Segmental aneurysmal dilatation and irregular wall thickening in the distal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis | 18.9 | None | Right hemicolectomy | 5-Year recurrence free |
74/female Our case | Abdominal pain Vomiting Diarrheal | Perforation of jejunum and ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >10/HPF IgG4/IgG >95% | 969 | None | Jejunum and ileum resection PSL 30 mg/day | 32-Months recurrence free |
Age (years) /Sex [Ref. No.] | Symptoms | Lesion | Histopathology and immunohistochemical staining | Serum IgG4 (mg/dl) | Other organ involvement | Treatment | Outcome |
---|---|---|---|---|---|---|---|
46/female [8] | Abdominal pain Vomiting | Jejunal ulcer | IgG4+ lymphoplasmacytic infiltration IgG4+ >60/HPF IgG4/IgG ratio >40% Necrotising mesenteric arteritis | 1540 | None | Jejunum resection →PSL, MMF | 5-week recurrence free |
43/male [9] | Abdominal pain | Ileum stricture and dilatation | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Fibrosis Obliterative phlebitis | N/A | None | Ileum resection | N/A |
55/male [10] | Abdominal pain General fatigue | Multiple erosions and ulcers of jejunum, stomach, and colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 70% | 2480 | AIP Cervical lymph node Nephritis (not biopsied) | PSL 40 mg/day | 3-month recurrence free |
70/male [11] | Abdominal pain Cognitive decline Gait disturbance | Multiple erosions and ulcers of ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 83.2% (dura) IgG4+ >90/HPF (dura) IgG4/IgG ratio >50% (ileum) IgG4+ >20/HPF (ileum) | 393 | Pachymeningitis | Steroid pulse therapy →PSL 10 mg/day | 2-month recurrence free |
54/female [12] | Colicky abdominal pain | Submucosal mass of terminal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis Obliterative phlebitis | N/A | None | Right hemicolectomy | 1-Year recurrence free |
72/female [13] | Abdominal pain Diarrheal | Chronic duodenitis and ileitis | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio >40% IgG4 >10/HPF | 2670 | Submandibular Pancreas | PSL 30 mg/day | 2-Year recurrence free |
69/male [14] | Repeated gastrointestinal tract obstruction | Two oedematous and stenosed lesions in ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 87% | 52.0 | None | Ileum resection | 1-Year recurrence free |
74/female [15] | Abdominal pain Slight fever | Oedematous and thick lesion from terminal ileum to lower ascending colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 50% IgG4 150/HPF | 102 | None | Right hemicolectomy | 10-Month recurrence free |
81/female [16] | Abdominal pain Dyspepsia Hematochezia | Segmental aneurysmal dilatation and irregular wall thickening in the distal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis | 18.9 | None | Right hemicolectomy | 5-Year recurrence free |
74/female Our case | Abdominal pain Vomiting Diarrheal | Perforation of jejunum and ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >10/HPF IgG4/IgG >95% | 969 | None | Jejunum and ileum resection PSL 30 mg/day | 32-Months recurrence free |
Abbreviations: AIP, Autoimmune pancreatitis; MMF, mycophenolate mofetil; N/A, not available.
Table3.
Open in new tab
The summary of cases of IgG4-RD with small intestinal lesion.
Age (years) /Sex [Ref. No.] | Symptoms | Lesion | Histopathology and immunohistochemical staining | Serum IgG4 (mg/dl) | Other organ involvement | Treatment | Outcome |
---|---|---|---|---|---|---|---|
46/female [8] | Abdominal pain Vomiting | Jejunal ulcer | IgG4+ lymphoplasmacytic infiltration IgG4+ >60/HPF IgG4/IgG ratio >40% Necrotising mesenteric arteritis | 1540 | None | Jejunum resection →PSL, MMF | 5-week recurrence free |
43/male [9] | Abdominal pain | Ileum stricture and dilatation | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Fibrosis Obliterative phlebitis | N/A | None | Ileum resection | N/A |
55/male [10] | Abdominal pain General fatigue | Multiple erosions and ulcers of jejunum, stomach, and colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 70% | 2480 | AIP Cervical lymph node Nephritis (not biopsied) | PSL 40 mg/day | 3-month recurrence free |
70/male [11] | Abdominal pain Cognitive decline Gait disturbance | Multiple erosions and ulcers of ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 83.2% (dura) IgG4+ >90/HPF (dura) IgG4/IgG ratio >50% (ileum) IgG4+ >20/HPF (ileum) | 393 | Pachymeningitis | Steroid pulse therapy →PSL 10 mg/day | 2-month recurrence free |
54/female [12] | Colicky abdominal pain | Submucosal mass of terminal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis Obliterative phlebitis | N/A | None | Right hemicolectomy | 1-Year recurrence free |
72/female [13] | Abdominal pain Diarrheal | Chronic duodenitis and ileitis | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio >40% IgG4 >10/HPF | 2670 | Submandibular Pancreas | PSL 30 mg/day | 2-Year recurrence free |
69/male [14] | Repeated gastrointestinal tract obstruction | Two oedematous and stenosed lesions in ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 87% | 52.0 | None | Ileum resection | 1-Year recurrence free |
74/female [15] | Abdominal pain Slight fever | Oedematous and thick lesion from terminal ileum to lower ascending colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 50% IgG4 150/HPF | 102 | None | Right hemicolectomy | 10-Month recurrence free |
81/female [16] | Abdominal pain Dyspepsia Hematochezia | Segmental aneurysmal dilatation and irregular wall thickening in the distal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis | 18.9 | None | Right hemicolectomy | 5-Year recurrence free |
74/female Our case | Abdominal pain Vomiting Diarrheal | Perforation of jejunum and ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >10/HPF IgG4/IgG >95% | 969 | None | Jejunum and ileum resection PSL 30 mg/day | 32-Months recurrence free |
Age (years) /Sex [Ref. No.] | Symptoms | Lesion | Histopathology and immunohistochemical staining | Serum IgG4 (mg/dl) | Other organ involvement | Treatment | Outcome |
---|---|---|---|---|---|---|---|
46/female [8] | Abdominal pain Vomiting | Jejunal ulcer | IgG4+ lymphoplasmacytic infiltration IgG4+ >60/HPF IgG4/IgG ratio >40% Necrotising mesenteric arteritis | 1540 | None | Jejunum resection →PSL, MMF | 5-week recurrence free |
43/male [9] | Abdominal pain | Ileum stricture and dilatation | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Fibrosis Obliterative phlebitis | N/A | None | Ileum resection | N/A |
55/male [10] | Abdominal pain General fatigue | Multiple erosions and ulcers of jejunum, stomach, and colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 70% | 2480 | AIP Cervical lymph node Nephritis (not biopsied) | PSL 40 mg/day | 3-month recurrence free |
70/male [11] | Abdominal pain Cognitive decline Gait disturbance | Multiple erosions and ulcers of ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 83.2% (dura) IgG4+ >90/HPF (dura) IgG4/IgG ratio >50% (ileum) IgG4+ >20/HPF (ileum) | 393 | Pachymeningitis | Steroid pulse therapy →PSL 10 mg/day | 2-month recurrence free |
54/female [12] | Colicky abdominal pain | Submucosal mass of terminal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis Obliterative phlebitis | N/A | None | Right hemicolectomy | 1-Year recurrence free |
72/female [13] | Abdominal pain Diarrheal | Chronic duodenitis and ileitis | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio >40% IgG4 >10/HPF | 2670 | Submandibular Pancreas | PSL 30 mg/day | 2-Year recurrence free |
69/male [14] | Repeated gastrointestinal tract obstruction | Two oedematous and stenosed lesions in ileum | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 87% | 52.0 | None | Ileum resection | 1-Year recurrence free |
74/female [15] | Abdominal pain Slight fever | Oedematous and thick lesion from terminal ileum to lower ascending colon | IgG4+ lymphoplasmacytic infiltration IgG4/IgG ratio 50% IgG4 150/HPF | 102 | None | Right hemicolectomy | 10-Month recurrence free |
81/female [16] | Abdominal pain Dyspepsia Hematochezia | Segmental aneurysmal dilatation and irregular wall thickening in the distal ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >50/HPF Storiform fibrosis | 18.9 | None | Right hemicolectomy | 5-Year recurrence free |
74/female Our case | Abdominal pain Vomiting Diarrheal | Perforation of jejunum and ileum | IgG4+ lymphoplasmacytic infiltration IgG4 >10/HPF IgG4/IgG >95% | 969 | None | Jejunum and ileum resection PSL 30 mg/day | 32-Months recurrence free |
Abbreviations: AIP, Autoimmune pancreatitis; MMF, mycophenolate mofetil; N/A, not available.
It is worth noting that in six out of nine cases, there was no involvement of other organs, suggesting that small intestinal lesions may develop independently without other typical organ involvement. Moreover, histopathological storiform fibrosis and obliterative phlebitis were less frequent. In a multicentre survey of IgG4-RD patients with gastrointestinal manifestations, only two out of eight cases demonstrated storiform fibrosis and obliterative phlebitis [19]. In addition, similar to our case, IgG4+ lymphoplasmacytic infiltration was found in the endoscopically normal mucosa in two cases [10, 13]. Regarding treatment, some cases had a favourable response to glucocorticoids [8, 10, 11, 13], which is consistent with the clinical features of IgG4-RD. On the other hand, as many cases archived a remission with surgical intervention [9, 12, 14–16], if the lesions are resected completely, a careful follow-up may be a good option. In our case, the patient experienced gastrointestinal manifestations and was repeatedly hospitalised due to ileus, resulting in small intestinal perforation requiring surgical intervention. IgG4-RD is a condition that is often misdiagnosed as other diseases. When presented with gastrointestinal manifestation with serum IgG4 elevation, it is important to consider differential diagnoses including inflammatory bowel diseases, systemic vasculitis, malignant lymphoma, and infectious diseases such as parasitosis.
Pathology revealed chronic inflammation due to diffuse and numerous IgG4+ plasmacyte infiltration in the gastrointestinal tract. Although neither typical organ involvements nor pathological findings such as storiform fibrosis and obliterative phlebitis were observed, we diagnosed IgG4-RD based on the following reasons: (1) chronic inflammation accompanied by abundant IgG4+ plasmacyte infiltration was detected not only in the small intestine but also in the stomach, duodenum, and colon; (2) other causes were completely ruled out; and (3) symptoms and CT abnormalities showed improvement following glucocorticoid therapy. In terms of pathophysiology, we found that the persistent inflammation due to the infiltration of IgG4+ plasmacytes may be responsible for chronic gastrointestinal manifestations. Moreover, this inflammatory process may contribute to the fragility of the gastrointestinal wall and arterial occlusion as a reactive change. It is important to mention that there were no pathological findings of polyarteritis or ANCA-RD, such as fibrinoid necrosis. Furthermore, there were no specific clinical features related to other systemic vasculitis. Therefore, it is suggested that chronic inflammation may have caused oedematous wall thickening, which could have led to a reduction in intestinal peristatic movement. Furthermore, surgical findings revealed the presence of strong interloop adhesions in the small intestine, which may have caused small intestinal ileus. In addition, persistent inflammation caused arterial occlusion, which resulted in subsequent ischaemic perforation of the small intestine.
In summary, we present the first case of IgG4-RD complicated by small intestinal perforation due to diffuse and chronic gastrointestinal inflammation. Because gastrointestinal lesions in IgG4-RD may manifest nonspecifically, IgG4-RD should be considered in the differential diagnosis for chronic gastrointestinal symptoms of unknown aetiology. Histopathological assessment, particularly not only of radiographic and endoscopic abnormalities but also normal mucosa, should be conducted to establish an accurate diagnosis of IgG4-RD with gastrointestinal lesion and to avoid fatal complications. In the future, further investigations are needed to clarify the characteristics of IgG4-RD complicated with gastrointestinal lesion.
Acknowledgements
The authors would like to express thanks to the kindness of the patient and her family and also gratefully acknowledge Drs Itaru Sanoyama and Hiroyuki Takahashi of the Department of Pathology, Kitasato University School of Medicine, for advice on pathological findings.
Conflict of interest
None declared.
Funding
None declared.
Patient consent
Written informed consent was obtained from the patient for publication.
Ethical approval
Not applicable.
References
[1]
Stone JH Zen Y Deshpande V
IgG4-related disease
.
N Engl J Med
2012
;
366
:
539
–
51
.
[2]
Kamisawa T Zen Y Pillai S
IgG4-related disease
.
Lancet
2015
;
385
:
1460
–
71
.
[3]
Lim DY Cheng LT Tan DMY
Isolated IgG4-related gastric disease presenting as diffuse gastric wall thickening with ulcer
.
J Radiol Case Rep
2018
;
12
:
9
–
20
.
[4]
Fujita T Ando T Sakakibara M
Refractory gastric ulcer with abundant IgG4-positive plasma cell infiltration: a case report
.
World J Gastroenterol
2010
;
16
:
2183
–
6
.
[5]
Bulanov D Arabadzhieva E Bonev S
A rare case of IgG4-related disease: a gastric mass, associated with regional lymphadenopathy
.
BMC Surg
2016
;
16
:37.
OpenURL Placeholder Text
[6]
Khan S Zhu LP Jiang K
Immunoglobulin G4-related disease manifesting as isolated, typical, and nontypical gastroesophageal lesion: a research of literature review
.
Digestion
2020
;
101
:
506
–
21
.
[7]
Cabrales-Escobar IE Murcio-Pérez E Albarrán-Sánchez A
IgG4-related disease manifesting as symptoms of appendicitis: case report and literature review
.
Clin J Gastroenterol
2021
;
14
:
626
–
32
.
[8]
Wong DD Pillai SR Kumarasinghe MP
IgG4-related sclerosing disease of the small bowel presenting as necrotizing mesenteric arteritis and a solitary jejunal ulcer
.
Am J Surg Pathol
2012
;
36
:
929
–
34
.
[9]
Ko Y Woo JY Kim JW
An immunoglobulin G4-related sclerosing disease of the small bowel: CT and small bowel series findings
.
Korean J Radiol
2013
;
14
:
776
–
80
.
[10]
Fujita K Naganuma M Saito E
Histologically confirmed IgG4-related small intestinal lesions diagnosed via double balloon enteroscopy
.
Dig Dis Sci
2012
;
57
:
3303
–
6
.
[11]
Yoshidome Y Mizoguchi A Narimatsu K
Immunoglobulin G4-related disease accompanying a small intestinal ulcer: a case
.
DEN Open
2022
;
2
:e76.
OpenURL Placeholder Text
[12]
Bhowmik S Bhattacharjee HK Abraham J
Isolated IgG4-related disease of terminal ileum: report of a rare case and review of literature
.
J Cancer Res Ther
2024
.
OpenURL Placeholder Text
[13]
Hirano T Kawakami Y Nakabayashi S
A case of immunoglobulin G4-related gastrointestinal disease diagnosed from persistent diarrhea and abdominal pain
.
Gastro Hep Advances
2023
;
2
:
1089
–
92
.
[14]
Watanabe A Goto T Kamo H
Resection of lesions in the ileum of patients with IgG4-related disease may ameliorate disease progression without steroid administration
.
Surg Case Rep
2018
;
4
:148.
OpenURL Placeholder Text
[15]
Hiyoshi Y Oki E Zaitsu Y
IgG4-related disease of the ileocecal region mimicking malignancy: a case report
.
Int J Surg Case Rep
2014
;
5
:
669
–
72
.
[16]
Kang S Lee YS Kim NH
Immunoglobulin G4-related disease of the small bowel: a case of long-term remission achieved by surgical resection without maintenance therapy
.
Korean J Gastroenterol
2023
;
82
:
25
–
9
.
[17]
Wallace ZS Naden RP Chari S
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
.
Ann Rheum Dis
2020
;
79
:
77
–
87
.
[18]
Umehara H Okazaki K Kawa S
Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW) Japan. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD
.
Mod Rheumatol
2021
;
31
:
529
–
33
.
[19]
Notohara K Kamisawa T Uchida K
Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey
.
J Gastroenterol
2018
;
53
:
845
–
53
.
© Japan College of Rheumatology 2024. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Issue Section:
Case Report
Download all slides
Advertisem*nt intended for healthcare professionals
Citations
Views
65
Altmetric
More metrics information
Metrics
Total Views 65
39 Pageviews
26 PDF Downloads
Since 3/1/2024
Month: | Total Views: |
---|---|
March 2024 | 5 |
April 2024 | 39 |
May 2024 | 10 |
June 2024 | 9 |
July 2024 | 2 |
Citations
Powered by Dimensions
Altmetrics
Email alerts
Article activity alert
Advance article alerts
New issue alert
Receive exclusive offers and updates from Oxford Academic
Citing articles via
Google Scholar
-
Most Read
-
Latest
More from Oxford Academic
Clinical Medicine
Medicine and Health
Rheumatology
Books
Journals
Advertisem*nt intended for healthcare professionals